SCHEMBL858732

SCHEMBL858732

Cc1ccc2[c]ncnc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.37
CYP1A2 P05177 3/20 0.36
NQO2 P16083 1/20 0.36
NCK1 P16333 1/20 0.33
BACE1 P56817 1/20 0.33
CHEK1 O14757 1/20 0.33
PARP1 P09874 1/20 0.33
PIM1 P11309 1/20 0.33
RPS6KA3 P51812 1/20 0.33
KDM4E B2RXH2 3/20 0.33
HTT P42858 2/20 0.33
MAPK1 P28482 1/20 0.33
FGFR1 P11362 1/20 0.32
HTR1A P08908 1/20 0.32
ADRA1D P25100 1/20 0.32
ADRA1A P35348 1/20 0.32
ADRA1B P35368 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
UHRF1 Q96T88 1/20 0.31
CCR1 P32246 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL855850 0.76 KDM4E (0.33) BACE1PARP1KDM4E
SCHEMBL855067 0.76 HTT (0.38) ALDH1A1CYP1A2BACE1KDM4EHTT
SCHEMBL856564 0.68 F7 (0.36) ALDH1A1CYP1A2PARP1KDM4EHTT
SCHEMBL17511896 0.68 PI4KA (0.43) ALDH1A1CYP1A2NQO2KDM4EMAPT
SCHEMBL4471481 0.68 ALDH1A1 (0.46) ALDH1A1CYP1A2NQO2CHEK1PARP1
SCHEMBL856888 0.67
SCHEMBL2356812 0.65 CYP1A2 (0.42) ALDH1A1CYP1A2NQO2NCK1BACE1
SCHEMBL15404712 0.64 ENPP1 (0.43) L3MBTL1LMNA
SCHEMBL14579633 0.64 CHEK1 (0.44) ALDH1A1CYP1A2NQO2CHEK1PARP1
SCHEMBL856169 0.64 MAP4K4 (0.39) BACE1PARP1KDM4EHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140107100-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-04-17 US disclosed
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2014-03-20 US disclosed
US-8648066-B2 Benzoxazepines as inhibitors of PI3K/mTOR and methods of their use and manufacture EXELIXIS, INC. (US) 2014-02-11 US disclosed
EP-2432779-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES Exelixis, Inc. (US) 2012-03-28 EP disclosed
US-20100298290-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture EXELIXIS, INC. (US) 2010-11-25 US disclosed
WO-2010135524-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES EXELIXIS, INC. (US) 2010-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298290-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA ALDH1A1 3395/4885CYP1A2 997/4885NQO2 1090/4885
US-20140107100-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA ALDH1A1 3533/4885CYP1A2 878/4885NQO2 1468/4885
US-20140080810-A1 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture MTOR, RICTOR, PIK3CA ALDH1A1 3049/4885CYP1A2 1244/4885NQO2 926/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.